Form 8-K · Current report
Las Vegas Sands 8-K, filed Oct 21, 2026
- Filed
- CIK
- 0001300514
- Accession no.
- 0001300514-26-000099
Summary
Las Vegas Sands reported third-quarter 2026 net revenue of $3.22 billion and net income of $352 million, down from $3.33 billion and $491 million a year earlier, and repurchased $950 million of its common stock during the quarter. The board announced a 20% increase in the company's recurring common stock dividend for the 2027 calendar year, raising the annual payout to $1.44 per share.
Key points
- Diluted earnings per share were $0.48 for the quarter, and consolidated adjusted property EBITDA was $1.12 billion, down from $1.34 billion in the prior-year quarter.
- Sands China Ltd. net revenues rose 1.4% to $1.93 billion while its net income fell 29.8% to $191 million.
- Chairman and CEO Patrick Dumont pointed to the Marina Bay Sands expansion in Singapore and growth in volumes across all gaming segments in Macao.
- Las Vegas Sands repurchased 62 million Sands China shares for about $101 million, raising its ownership of Sands China to 75.56% as of September 30, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
ITEM 2.02. Results of Operations and Financial Condition. The following information is being furnished under Item 2.02 - Results of Operations and Financial Condition. On October 21, 2026, Las Vegas Sands Corp. (the “Company”) issued a press release announcing its results of operations for the third quarter ended September 30, 2026. The press release is attached as Exhibit 99.1 to this report and is incorporated by reference into this item. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.